Lexicon Pharmaceuticals, Inc. (LXRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 417.51M |
| Enterprise Value | 445.42M |
| P/E Ratio | -12.25 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 20.57 |
| Price/Book Ratio | 4.83 |
| Enterprise/Revenue | 20.97 |
| Enterprise/EBITDA | -14.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -1.62 |
| Operating Margin | -1.47 |
| Return On Assets | -0.26 |
| Return On Equity | -0.38 |
| Revenue | 49.8M |
| Revenue/Share | 0.09 |
| Gross Profit | 49.53M |
| EBITDA | -41.38M |
| Net Income | -50.34M |
| Diluted EPS | -0.14 |
| Total Cash | 183.2M |
| Total Cash/Share | 0.41 |
| Total Debt | 59.54M |
| Total Debt/Equity | 0.36 |
| Current Ratio | 10.63 |
| Book Value Per Share | 0.37 |
| 52-Week Change | 21.92 |
| 52-Week High | 2.68 |
| 52-Week Low | 1.1 |
| Moving Average 50 Days | 1.76 |
| Moving Average 200 Days | 1.9 |
| Average Volume | 2.6M |
| Shares Outstanding | 445.23M |
| % Held by Institutions | 84.37 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | May 21, 2015 |